Asset profile
AGT103-T
Gene therapy / editing
Evidence outlook · lead readout
NCT04561258 · HIV
The reported results come from study designs that frequently fail to replicate under controlled conditions — see the rationale below.
NCT04561258: There was no randomization, no blinding, and no comparator group in this very small study, so any findings cannot be attributed to the treatment with confidence, and no results have been posted yet.
The reservoir finding is an exploratory biomarker outcome, and the sponsor's report does not name the registry identifier for this study.
How the evidence outlook works ↗
Featured trials
Unlock featured-trial analysis
Research includes the instrumental studies, endpoints, key results, design grades, rationales and source links behind the Outlook.
Upcoming events
No upcoming readouts on record for this asset.
All registered studies
Unlock the complete ClinicalTrials.gov registry
Research includes every linked study, indication filters, phase grouping and featured-trial cross-links.
Competitive landscape
Unlock the competitor landscape
Research compares assets by shared mechanism and indication, including each competitor's stage in the relevant market.